Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Assmann

Showing results (11-20 of 495) with videos related to

Pageof 50
Sort By:
Fortschritte Der Medizin|May 10, 1991
[Lipid metabolism disorders: diagnosis and treatment. 2: Diagnostic-therapeutic staged scheme. Nationale Cholesterin-Initiative]G Assmann
Acta Cardiologica|January 1, 1989
Dietary and genetic effects on plasma lipid concentrationsG Assmann
Pharmacological Research|March 1, 1997
Simvastatin in the secondary prevention of coronary heart diseaseG Assmann
Acta Medica Scandinavica. Supplementum|January 1, 1987
Lipoproteins and apolipoproteins in the prediction of coronary artery diseaseG Assmann
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? European guidelinesG Assmann
Der Internist|February 7, 1998
[Increased CK in lipid-lowering therapy]G Assmann
Der Internist|November 30, 1999
[Secondary coronary heart disease prevention by red wine?]G Assmann
Die Medizinische Welt|August 26, 1977
[Diagnosis of hyperlipidemias]G Assmann
Fortschritte Der Medizin|June 10, 1991
[Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative]G Assmann
Cardiology|January 1, 1991
Drugs affecting HDL cholesterolG Assmann
Pageof 50

Showing results (11-20 of 495) with videos related to

Sort By:
Pageof 50
Fortschritte Der Medizin|May 10, 1991
[Lipid metabolism disorders: diagnosis and treatment. 2: Diagnostic-therapeutic staged scheme. Nationale Cholesterin-Initiative]G Assmann
Acta Cardiologica|January 1, 1989
Dietary and genetic effects on plasma lipid concentrationsG Assmann
Pharmacological Research|March 1, 1997
Simvastatin in the secondary prevention of coronary heart diseaseG Assmann
Acta Medica Scandinavica. Supplementum|January 1, 1987
Lipoproteins and apolipoproteins in the prediction of coronary artery diseaseG Assmann
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? European guidelinesG Assmann
Der Internist|February 7, 1998
[Increased CK in lipid-lowering therapy]G Assmann
Der Internist|November 30, 1999
[Secondary coronary heart disease prevention by red wine?]G Assmann
Die Medizinische Welt|August 26, 1977
[Diagnosis of hyperlipidemias]G Assmann
Fortschritte Der Medizin|June 10, 1991
[Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative]G Assmann
Cardiology|January 1, 1991
Drugs affecting HDL cholesterolG Assmann
Pageof 50